General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0MGBOF
ADC Name
huNb26/Nb26-Nbh-MMAE
Synonyms
huNb26/Nb26-Nbh-MMAE
   Click to Show/Hide
Organization
Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital.
Drug Status
Investigative
Drug-to-Antibody Ratio
1
Structure
Antibody Name
huNb26/Nb26-Nbh
 Antibody Info 
Antigen Name
Nectin-4 (NECTIN4)
 Antigen Info 
Payload Name
Monomethyl auristatin E
 Payload Info 
Therapeutic Target
Microtubule (MT)
 Target Info 
Linker Name
Mc-Val-Cit-PABC
 Linker Info 
Conjugate Type
Random conjugation through reduced inter-chain cysteines.
Combination Type
Vedotin
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal inhibitory Concentration (lC50) 
44.63
nM
CVCL_1603
Gastric tubular adenocarcinoma
Half Maximal Effective Concentration (EC50) 
1.04
nM
CVCL_1603
Gastric tubular adenocarcinoma
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) 44.63 nM Low NECTIN4 expression (NECTIN4+)
Method Description
Cells in the exponential growth phase were harvested and seeded at a density of 4 × 103 cells per well into 96-well plates, followed by overnight incubation. The 96-well plate was filled with gradient dilutions of the NDC along with complete growth medium. Cells were incubated at 37 °C for 96 h. 20 uL of cell counting Kit-8 (Dojindo) was administered to the cells, which were then incubated at 37 °C for 4 h. After shaking the 96-well plates, absorbance was measured at 450 nm using an enzyme marker. Inhibition % = (1 - absorbance of experimental group) / average absorbance of blank group × 100. IC50 values were ascertained by non-linear regression analysis utilizing GraphPad Prism version 8.0.

   Click to Show/Hide
In Vitro Model Gastric tubular adenocarcinoma NCI-N87 cells CVCL_1603
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 1.04 nM Low NECTIN4 expression (NECTIN4+)
Method Description
Cells in the exponential growth phase were harvested and seeded at a density of 4 × 103 cells per well into 96-well plates, followed by overnight incubation. The 96-well plate was filled with gradient dilutions of the NDC along with complete growth medium. Cells were incubated at 37 °C for 96 h. 20 uL of cell counting Kit-8 (Dojindo) was administered to the cells, which were then incubated at 37 °C for 4 h. After shaking the 96-well plates, absorbance was measured at 450 nm using an enzyme marker. Inhibition % = (1 - absorbance of experimental group) / average absorbance of blank group × 100. IC50 values were ascertained by non-linear regression analysis utilizing GraphPad Prism version 8.0.

   Click to Show/Hide
In Vitro Model Gastric tubular adenocarcinoma NCI-N87 cells CVCL_1603
References
Ref 1 A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer